Ambu stock trades at EUR 10.32 with a 40.81 price-to-earnings ratio

Published on 10/15/2026 at 22:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ambu's next annual report is scheduled for November 5, 2026. Ambu stock costs EUR 10.32 on October 15, 2026, with a 40.81 price-to-earnings ratio.

Analyst view leads the update

UBS lowered its Ambu target from DKK 96.00 to DKK 72.00 on September 15, 2026.
Ambu's annual report is scheduled for November 5, 2026.
Ambu stock costs EUR 10.32 at Lang & Schwarz on October 15, 2026 at 10:41 p.m. CEST.
Ambu's market capitalization was DKK 18.1 billion on October 15, 2026.

Bauhaus-Poster mit geometrischen Formen und Sektor-Schriftzug MEDTECH — Ambu A/S (DK0060946788) interpretiert die Medizintechnik-Branche als geometrisches Bauhaus-Poster mit farbigen Formen und Sektortext, Illustration mit AI erstellt.

UBS lowered its 12-month target for Ambu from DKK 96.00 to DKK 72.00 on September 15, 2026, putting the target 7.63 percent below Ambu's DKK 77.95 quote. Investing.com reported that UBS also cut its rating from buy to neutral, citing repeated earnings estimate resets and concerns about the company's margin ambition. Ambu stock was trading at EUR 10.32 at Lang & Schwarz on October 15, 2026 at 10:41 p.m. CEST.

Target distance matters for valuation

The UBS target remains below the latest DKK quote, while the current euro quotation gives German investors a separate trading reference. Ambu's market capitalization was DKK 18.1 billion on October 15, 2026. The company is valued at a price-to-earnings ratio of 40.81, and its trailing dividend yield was 0.01 percent.

Annual report date is November 5

Ambu's next scheduled corporate milestone is its annual report for fiscal year 2025/26 on November 5, 2026. The investor-relations calendar also lists the annual general meeting for December 2, 2026, followed by the first-quarter earnings release on January 28, 2027, according to Ambu.

Ambu operates in single-use endoscopy, with respiratory products forming a key part of its portfolio. The investor-relations page describes the company as a medical-device business focused on single-use endoscopy and lists its respiratory, video laryngoscopy and one-lung ventilation products.

Home-currency range frames the stock

Ambu's DKK 56.25 to DKK 109.00 52-week range places the latest DKK quote inside a broad trading band. The current quote is 38.47 percent above the 52-week low and 28.49 percent below the 52-week high, using the same DKK price basis.

Price and investor perspective

The analyst target, the valuation multiple and the November reporting date provide three distinct reference points for following Ambu stock. The target cut is dated September 15, 2026, while the next company milestone is dated November 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Ambu stock.